Actively Recruiting
Clinical Outcome Assessment for AT & BCI
Led by Shirley Ryan AbilityLab · Updated on 2026-05-05
60
Participants Needed
1
Research Sites
72 weeks
Total Duration
On this page
Sponsors
S
Shirley Ryan AbilityLab
Lead Sponsor
N
Neuralink Corp
Collaborating Sponsor
AI-Summary
What this Trial Is About
Many individuals with severe motor impairments rely on Assistive Technologies (ATs) or Brain-Computer Interfaces (BCIs) to interact with digital devices such as their computers. Clinicians and researchers currently lack a common framework to objectively quantify how much a given AT or BCI improves real-world function or to compare across tools. This project seeks to address this gap by developing a standardized method to objectively assess or compare the functional benefit of these tools on digital independence, i.e., the ability to independently operate computers, phones, and other digital systems, by creating a unique Digital Assessment Interface (DAI). This assessment will be a simulation of online and digital activities that prior work has determined is important to functional daily living in the digital domain. Participants will complete this assessment with various ATs and BCIs, and these scores will be used to create an index, which will be comprised of performance outcomes, clinician-reported outcomes, and patient-reported outcomes. The tool aims to quantify and compare digital task performance across devices and user populations. The primary objective of this study is to develop an index. The index will quantify functional performance of individuals using various ATs and BCIs. The secondary objectives are to extensively evaluate the psychometric properties of the index, such as the validity, responsiveness, reliability, and floor/ceiling effects both globally and across different devices and impairment levels, ensuring that it can reliably measure the impact of an AT or BCI on a user's ability to independently operate digital systems; and to characterize the familiarization and use of specific BCI and AT systems with reference to a normative healthy control population.
CONDITIONS
Official Title
Clinical Outcome Assessment for AT & BCI
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Diagnosis of spinal cord injury at the level between C1 and T1
- Ability to communicate independently, with a support device, or with a legal representative
- Ability to participate in study sessions lasting about 3 hours with breaks as needed
- Diagnosis of amyotrophic lateral sclerosis (ALS)
- No history of neurological or psychiatric disorders for healthy controls
- Ability to provide written informed consent for healthy controls
You will not qualify if you...
- Participation in another trial that conflicts with this study or may interfere with clinical endpoints
- Cognitive, visual, or auditory deficits interfering with participation for healthy controls
- Current or prior diagnosis or condition that could confound study assessments for healthy controls
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shirley Ryan AbilityLab
Chicago, Illinois, United States, 60611
Actively Recruiting
Research Team
A
Arun Jayaraman, PT, PhD
CONTACT
R
Richa Rai, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
CROSSOVER
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here